<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pntd.0008304.t001" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pntd.0008304.t001</object-id>
 <label>Table 1</label>
 <caption>
  <title>Parameter estimates and outcomes for both model variants.</title>
 </caption>
 <alternatives>
  <graphic id="pntd.0008304.t001g" xlink:href="pntd.0008304.t001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th align="left" rowspan="1" colspan="1"/>
     <th align="left" rowspan="1" colspan="1">FOI model, median estimate (95% Credibility Interval)</th>
     <th align="left" rowspan="1" colspan="1">R
      <sub>0</sub> model, median estimate (95% Credibility Interval)
     </th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td align="left" rowspan="1" colspan="1">
      <bold>
       <italic>Model parameters</italic>
      </bold>
     </td>
     <td align="left" rowspan="1" colspan="1"/>
     <td align="left" rowspan="1" colspan="1"/>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">GLM Area under the Curve</td>
     <td align="left" rowspan="1" colspan="1">0.916 (0.909–0.921)</td>
     <td align="left" rowspan="1" colspan="1">0.916 (0.908–0.921)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Minimum per-infection probability of detection</td>
     <td align="left" rowspan="1" colspan="1">3.6e-7 (2.1e-8–2.9e-6), Guinea-Bissau</td>
     <td align="left" rowspan="1" colspan="1">6.2e-7 (4.5e-8–3.6e-6), Guinea-Bissau</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Maximum per-infection probability of detection</td>
     <td align="left" rowspan="1" colspan="1">1.9e-5 (9.0e-6–3.8e-5), Central African Republic</td>
     <td align="left" rowspan="1" colspan="1">3.0e-5 (1.8e-5–5.1e-5), Central African Republic</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Vaccine efficacy</td>
     <td align="left" rowspan="1" colspan="1">0.952 (0.749–0.993)</td>
     <td align="left" rowspan="1" colspan="1">0.942 (0.671–0.993)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">
      <bold>
       <italic>Burden estimates</italic>
      </bold>
     </td>
     <td align="left" rowspan="1" colspan="1"/>
     <td align="left" rowspan="1" colspan="1"/>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">1995 number of deaths</td>
     <td align="left" rowspan="1" colspan="1">110,000 (40,000–280,000)</td>
     <td align="left" rowspan="1" colspan="1">120,000 (50,000–320,000)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">2005 number of deaths</td>
     <td align="left" rowspan="1" colspan="1">130,000 (50,000–320,000)</td>
     <td align="left" rowspan="1" colspan="1">60,000 (20,000–210,000)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">2017 number of deaths</td>
     <td align="left" rowspan="1" colspan="1">110,000 (40,000–270,000)</td>
     <td align="left" rowspan="1" colspan="1">30,000 (4,000–120,000)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">2017 number of severe cases</td>
     <td align="left" rowspan="1" colspan="1">240,000 (90,000–620,000)</td>
     <td align="left" rowspan="1" colspan="1">70,000 (9,000–270,000)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">2017 total number of infections</td>
     <td align="left" rowspan="1" colspan="1">2,190,000 (1,310,000–3,710,000)</td>
     <td align="left" rowspan="1" colspan="1">670,000 (100,000–1,790,000)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">2017 total number of DALYs lost</td>
     <td align="left" rowspan="1" colspan="1">5,400,000 (1,900,000–13,600,000)</td>
     <td align="left" rowspan="1" colspan="1">1,700,000 (240,000–7,000,000)</td>
    </tr>
    <tr>
     <td align="left" colspan="3" rowspan="1">
      <bold>
       <italic>Lifetime vaccine impact estimates</italic>
      </bold>
      <xref ref-type="table-fn" rid="t001fn002">*</xref>
      <bold>
       <italic>of 2005–2017 PMVCs</italic>
      </bold>
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Deaths prevented</td>
     <td align="left" rowspan="1" colspan="1">3,300,000 (1,200,000–7,700,000)</td>
     <td align="left" rowspan="1" colspan="1">6,100,000 (2,400,000–13,200,000)</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">DALY prevented</td>
     <td align="left" rowspan="1" colspan="1">145,800,000 (53,700,000–345,700,000)</td>
     <td align="left" rowspan="1" colspan="1">327,900,000 (133,000,000–699,300,000)</td>
    </tr>
   </tbody>
  </table>
 </alternatives>
 <table-wrap-foot>
  <fn id="t001fn001">
   <p>DALYs: disability-adjusted life years; PMVCs: Preventive mass vaccination campaigns.</p>
  </fn>
  <fn id="t001fn002">
   <p>*Lifetime vaccine impact is defined as the cumulative difference over the 2000–2100 time period in baseline burden estimates and those estimated had the 2005–2017 PMVCs not taken place. The 2000–2100 time horizon ensures to capture vaccine impact over most of the lifetime of people vaccinated and those benefitting from the resulting herd immunity.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
